Streptococcus agalactiae와 Streptococcus dysagalactiae에 의한 사슬알균 독소충격증후군 2례
Two Cases of Streptococcal Toxic Shock Syndrome Caused by Streptococcus agalactiae and Streptococcus dysagalactiae
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Streptococcal toxic shock syndrome (STSS) is an acute, progressive illness that manifests with fever, hypotension, and accelerated multi-organ failure. It is usually caused by Group A Streptococcus (Streptococcus pyogenes ). STSS due to nongroup A streptococci is rare, but its incidence has recently increased. We report here on two cases of STSS caused by Group B Streptococcus (Streptococcus agalactiae) and Group G Streptococcus (Streptococcus dysagalactiae).
Abstract
Streptococcal toxic shock syndrome (STSS) is an acute, progressive illness that manifests with fever, hypotension, and accelerated multi-organ failure. It is usually caused by Group A Streptococcus (Streptococcus pyogenes ). STSS due to nongroup A streptococci is rare, but its incidence has recently increased. We report here on two cases of STSS caused by Group B Streptococcus (Streptococcus agalactiae) and Group G Streptococcus (Streptococcus dysagalactiae).
참고문헌 (15)
- Cone LA, "Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes", N Engl J Med, 317, pp.146~149 (1987)
- Tang WM, "Report of 2 fatal cases of adult necrotizing fasciitis and toxic shock syndrome caused by Streptococcus agalactiae", Clin Infect Dis, 31, pp.E15~E17 (2000)
- Reich HL, "Group B streptococcal toxic shock-like syndrome", Arch Dermatol, 140, pp.163~166 (2004)
- Wagner JG, "Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review", Clin Infect Dis, 23, pp.1159~1161 (1996)
- 이신원, "Group G streptococcus에 의한 독소충격증후군 1례", Infection and Chemotherapy, 42(3), pp.187~189 (2010), 대한감염학회
- Horii T, "Acute peritonitis and salpingitis associated with streptococcal toxic shock syndrome caused by Lancefield group G alpha-haemolytic Streptococcus dysgalactiae subsp. equisimilis", J Med Microbiol, 55, pp.953~956 (2006)
- Schuchat A, "Group B streptococcus", Lancet, 353, pp.51~56 (1999)
- Gaviria JM, "Group C and G streptococci, in Streptococcal infections: clinical aspects, microbiology, and molecular biology", pp.180~221 (2000), Oxford University Press
- Lappin E, "Gram-positive toxic shock syndromes", Lancet Infect Dis, 9, pp.281~290 (2009)
- 신종욱, "Streptococcal Toxic Shock Syndrome Secondary to Salpingitis and Panperitonitis in aPreviously Healthy Nongravid Woman", Infection and Chemotherapy, 37(1), pp.55~59 (2005), 대한감염학회
- Cho JK, "A case of streptococcal toxic shock syndrome with myonecrosis", Korean J Infect Dis, 32, pp.456~461 (2000)
- Müller-Alouf H, "Superantigen bacterial toxins: state of the art", Toxicon, 39, pp.1691~1701 (2001)
- Brandt CM, "Human infections due to streptococcus dysgalactiae subspecies equisimilis", Clin Infect Dis, 49, pp.766~772 (2009)
- Tan JS, "Streptococcus species, in Antimicrobial therapy and vaccines", pp.736~ (2002), Apple tree productions, LLC
- Mascini EM, "Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci", Int J Antimicrob Agents, 18, pp.395~398 (2001)